Christopher James | Vice President of Investor Relations at Collegium Pharmaceuticals |
Joe Ciaffoni | Chief Executive Officer |
Colleen Tupper | Chief Financial Officer |
Scott Dreyer | Chief Commercial Officer |
David Amsellem | Piper Sandler |
Brandon Folkes | Cantor Fitzgerald |
Serge Belanger | Needham & Company |
Greg Fraser | Truist |
Greetings, and welcome to the Collegium Pharmaceutical Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.
[Operator Instructions] Please note, that this conference call is being recorded. I will now turn the call over to Christopher James, Vice President of Investor Relations at Collegium.